Back

Lipomatous metaplasia is the best CT predictor for conducting channel localization in scar-related ventricular tachycardia ablation

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Ventricular arrhythmias and sudden cardiac death in cardiomyopathies Ablation of Ventricular Arrhythmias ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Giulio Zucchelli

University Hospital of Pisa, Pisa (Italy)

5 More presentations in this session

Presentation thumbnail
Ventricular arrhythmia outcomes in hypertrophic cardiomyopathy from a high level myectomy centre
Doctor M. Gupta (Pittsburgh, US)
Abstract Slides Video
Presentation thumbnail
Long-term follow-up in patients with hypertrophic cardiomyopathy after defibrillator implantation: analysis of appropriate and inappropriate therapy
Miss E. Basse Christensen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Homozygous or compound heterozygous variants in DSG2 are mainly causative of Japanese arrhythmogenic right ventricular cardiomyopathy.
Doctor K. Sonoda (Suita, JP)
Abstract Slides Video
Presentation thumbnail
The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathy
Mr F. Kirkels (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
The benefit of a double ventricular extra stimuli protocol to improve functional substrate mapping during ablation of ventricular tachycardia. - The S3-VT-FREE project
Mrs M. Regany (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular arrhythmias and sudden cardiac death in cardiomyopathies
Video

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources